StreetAlpha
13F holdings · Q3 2026

BlackBarn Capital Partners

New York, NY · files as BlackBarn Capital Partners LP
Know the moment BlackBarn Capital Partners filesYou follow BlackBarn Capital Partners An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 2010204

BlackBarn Capital Partners reported 18 stocks worth $510M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AZUL (30.6%), PRVA (9.4%) and ROIV (9.4%). Compared with Q2 2026, the fund opened new positions in NXT, TMO and CSW, added to AZUL, PRVA and NXPI, trimmed ROIV, DHC and MH and sold out of NIQ, UNH and AMRX.

Latest filing: what BlackBarn Capital Partners did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
5 new3 added6 trimmed4 sold outBought about $232M · sold about $124M
New 5
Added 3
Trimmed 6
  • ROIV−$23M−33%
  • VG−$8.3M−43%
  • VKTX−$3.1M−13%
  • MH−$1.7M−7%
  • ABUS−$1.4M−11%
See all 6 →
Sold out 4

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$510M+26.7% vs last quarter · $1.2B including options
Stocks held185 new · 4 sold out
Top 5 weight62.8%very concentrated
Turnover70%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
AZUL
Azul Sa-Spon ADR
$156M30.6%17.3M+15.7M (+930%)2 of 8
2
PRVA
Privia Health Group Inc
$48.1M9.4%1.9M+285K (+18%)8 of 8
3
ROIV
Roivant Sciences Ltd
$47.8M9.4%1.4M−650K (−33%)8 of 8
4
DHC
Diversified Healthcare TR
$37.2M7.3%4M−75K (−2%)8 of 8
5
NXT
Nextracker Inc
$31.3M6.2%263KNew position4 of 8
6
NXPI
Nxp Semiconductors N V
$29.8M5.8%106K+16K (+18%)3 of 8
7
NEE
Nextera Energy Inc
$29.4M5.8%335KNo change6 of 8
8
TMO
Thermo Fisher Scientific Inc
$22.6M4.4%45KNew position1 of 8
9
MH
McGraw Hill Inc
$21.5M4.2%2.3M−175K (−7%)5 of 8
10
VKTX
Viking Therapeutics Inc
$20.3M4.0%520K−80K (−13%)6 of 8
🔒 8 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
NIQ
Niq Global Intelligence PLC
$27.2M2.9M
UNH
Unitedhealth Group Inc
$27M65K
AMRX
Amneal Pharmaceuticals Inc
$22.5M1.3M
CRC
California Res Corp
$9.3M175K

Options

valued at the underlying shares
StockTypeValueSharesChange
SPY
Spdr S&P 500 ETF TR
Put$448M600K−200,000
HYG
Ishares TR
Put$80M1M+1,000,000
HUM
Humana Inc
Put$39.7M100K+100,000
LLY
Eli Lilly & Co
Put$30M25K+25,000
OSCR
Oscar Health Inc
Put$28.5M1M−750,000

🔒 Free account: see all 9.

Reported value

last 8 quarters
$254MQ4 '24
$293MQ1 '25
$302MQ2 '25
$306MQ3 '25
$279MQ4 '25
$332MQ1 '26
$402MQ2 '26
$510MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

BlackBarn Capital Partners 13F FAQ

What does BlackBarn Capital Partners own?

BlackBarn Capital Partners reported 18 stocks worth $510M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AZUL (30.6%), PRVA (9.4%) and ROIV (9.4%). The table above lists every position in the filing (the top 10 without an account).

What did BlackBarn Capital Partners buy and sell in Q3 2026?

Compared with Q2 2026: 5 new positions, 3 added to, 6 trimmed and 4 sold out. New positions include NXT, TMO and CSW. It sold all of NIQ, UNH and AMRX.

When will BlackBarn Capital Partners file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is BlackBarn Capital Partners's portfolio worth?

The Q3 2026 filing reports $510M in US stocks ($1.2B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.